Cargando…
Combined Therapy of Experimental Autoimmune Uveitis by a Dual-Drug Nanocomposite Formulation with Berberine and Dexamethasone
PURPOSE: Autoimmune uveitis is a kind of sight-threatening ocular and systemic disorders. Recent treatments on autoimmune uveitis still remain many limitations due to extreme complexity and undetermined pathogenesis. In this study, a novel dual-drug nanocomposite formulation is developed to treat ex...
Autores principales: | Huang, Chang, Zhang, Zhutian, Gu, Jifeng, Li, Dan, Gao, Shunxiang, Zhang, Rong, Shi, Rong, Sun, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402891/ https://www.ncbi.nlm.nih.gov/pubmed/37545873 http://dx.doi.org/10.2147/IJN.S417750 |
Ejemplares similares
-
Integrated Transcriptome Analysis of Iris Tissues in Experimental Autoimmune Uveitis
por: Li, Dan, et al.
Publicado: (2022) -
Long-acting acid-sensitive ketal-linked dexamethasone microcrystals for treating experimental autoimmune uveitis
por: Cai, Maoyu, et al.
Publicado: (2022) -
IL-33 attenuates the development of experimental autoimmune uveitis
por: Barbour, Mark, et al.
Publicado: (2014) -
Experimental autoimmune uveitis and other animal models of uveitis: An update
por: Bansal, Svati, et al.
Publicado: (2015) -
Parental Uveitis Influences Offspring With an Increased Susceptibility to the Experimental Autoimmune Uveitis
por: Yin, Guangnian, et al.
Publicado: (2020)